Simultaneous determination of the HIV nucleoside analogue reverse transcriptase inhibitors lamivudine, didanosine, stavudine, zidovudine and abacavir in human plasma by reversed phase high performance liquid chromatography.
about
A novel LC-MS/MS method for simultaneous quantification of tenofovir and lamivudine in human plasma and its application to a pharmacokinetic study.Steady-state nevirapine, lamivudine and stavudine levels in Malawian HIV-infected children on antiretroviral therapy using split Triomune 30 tabletsCovariate effects and population pharmacokinetics of lamivudine in HIV-infected children.Dose evaluation of lamivudine in human immunodeficiency virus-infected children aged 5 months to 18 years based on a population pharmacokinetic analysis.Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-<36 months.Stress Degradation Behavior of Abacavir Sulfate and Development of a Suitable Stability-Indicating UHPLC Method for the Determination of Abacavir, its Related Substances, and Degradation Products.Analysis of in vivo absorption of didanosine tablets in male adult dogs by HPLC.Development and validation of a normal-phase HPTLC method for the simultaneous analysis of Lamivudine and Zidovudine in fixed-dose combination tablets.A stability-indicating LC-MS/MS method for zidovudine: Identification, characterization and toxicity prediction of two major acid degradation products.
P2860
Q34119862-A97E807F-565F-49CE-992A-3E0433627ECAQ36806049-8313662D-EB45-419A-9724-31A2403C25ACQ37731863-4CA3AFD4-3093-4B7B-90B4-BE07B8356288Q38771392-B5034A5D-61F4-4B65-8237-EFB038317216Q41881433-7EC0340C-C97C-4AEF-8B5D-12494172F323Q42425202-E670BEDA-D622-4612-9DF5-4AF56E2E126CQ49165327-BB27FAA1-9DB9-4757-B666-F15586F566CFQ49883420-83FFCDEF-B9A2-4A4C-9066-C91E1AA3BCF5Q50057987-025DC37D-862C-4C1E-B1BE-FA48AC5CAE3A
P2860
Simultaneous determination of the HIV nucleoside analogue reverse transcriptase inhibitors lamivudine, didanosine, stavudine, zidovudine and abacavir in human plasma by reversed phase high performance liquid chromatography.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Simultaneous determination of ...... ormance liquid chromatography.
@en
Simultaneous determination of ...... ormance liquid chromatography.
@nl
type
label
Simultaneous determination of ...... ormance liquid chromatography.
@en
Simultaneous determination of ...... ormance liquid chromatography.
@nl
prefLabel
Simultaneous determination of ...... ormance liquid chromatography.
@en
Simultaneous determination of ...... ormance liquid chromatography.
@nl
P2093
P1476
Simultaneous determination of ...... ormance liquid chromatography.
@en
P2093
C P W G M Verweij-van Wissen
D M Burger
R E Aarnoutse
P304
P356
10.1016/J.JCHROMB.2004.11.019
P577
2005-02-01T00:00:00Z